Samumed to announce clinical data on potential treatment of androgenetic alopecia at WCHR

November 18, 2015

SAN DIEGO--November 18, 2015--Samumed, LLC, a leader in tissue regeneration, announced today that it will present clinical data on a small molecule (SM04554, an investigational new drug) for potential treatment of androgenetic alopecia (AGA), commonly known as male pattern baldness, at the 9th World Congress for Hair Research (WCHR) in Miami, Florida. The company is a Silver Sponsor of the meeting.

In preclinical in vivo studies, SM04554 has been shown to regenerate new hair follicles and increase hair count in multiple animal models. The company has finished a Phase I trial and is about to complete its Phase II trial with the same potential AGA treatment. At the WCHR, Samumed will present clinical results detailing safety, pK, and patient and investigator-reported efficacy data from a 28-day (14 day dosing, 14 days of follow-up), placebo-controlled, double-blind, randomized Phase I clinical trial of SM04554 in male AGA patients between the ages of 18 and 60 with Norwood-Hamilton Classification scores of 4, 5, 6, or 7.

"We are excited to present at the WCHR shortly after we presented results from our osteoarthritis program at the Annual Meeting of the American College of Rheumatology on November 9. Our technology platform focuses on small molecule drugs to repair/regenerate local tissue as diverse as hair and cartilage. Last week, we had shared both preclinical and clinical data from our osteoarthritis program, and this week we are excited to share clinical results from our alopecia program. We hope to present Phase II results from our AGA program very soon," said Yusuf Yazici, M.D., Chief Medical Officer of Samumed.

SAMUMED'S WCHR 2015 ORAL PRESENTATION

Saturday, November 21, 2015; 12:15pm

Safety and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia (AGA): Results from a Phase I Trial Session Title: Clinical Trials
-end-
ABOUT SAMUMED, LLC

Based in San Diego, CA, Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. Samumed has discovered new targets and biological processes in the Wnt pathway, allowing the team to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.

Rasky Baerlein Strategic Communications

Related Tissue Regeneration Articles from Brightsurf:

WFIRM scientists create hybrid tissue construct for cartilage regeneration
Wake Forest Institute for Regenerative Medicine scientists have developed a method to bioprint a type of cartilage that could someday help restore knee function damaged by arthritis or injury.

Researchers characterize important regulators of tissue inflammation, fibrosis and regeneration
Although macrophages (cells involved in the detection and destruction of bacteria and other harmful organisms as well as dead cells) are classified as immune cells functioning in the activation and resolution of tissue inflammation, it is now clear that they are critically involved in a variety of disease processes, such as chronic inflammatory diseases, tumor growth and metastasis and tissue fibrosis.

(Re)generation next: Novel strategy to develop scaffolds for joint tissue regeneration
In Japan, an increase in the aging population has exacerbated the demand for regenerative medicine to address increasingly common diseases, such as knee osteoarthritis.

Stem cells and nerves interact in tissue regeneration and cancer progression
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways.

Researchers show that mutations in human livers can promote tissue regeneration
Researchers at the Children's Medical Center Research Institute at UT Southwestern have identified genetic mutations that accumulate in the adult liver that can promote regeneration in the context of chronic liver damage.

The regeneration of a cell depends on where it is positioned
Researchers at the Nara Institute of Science and Technology (NAIST) report a new single-cell RNA sequencing technology, single cell-digital gene expression, which can measure the transcriptome while preserving the positional information of the cell in the tissue.

In vivo data show effects of spaceflight microgravity on stem cells and tissue regeneration
A new review of data from 12 spaceflight experiments and simulated microgravity studies has shown that microgravity does not have a negative effect on stem-like cell-dependent tissue regeneration in newts, but in some tissues regeneration is faster and more robust.

The genetics of regeneration
Led by Assistant Professor of Organismic and Evolutionary Biology Mansi Srivastava, a team of researchers is shedding new light on how animals perform whole-body regeneration, and uncovered a number of DNA switches that appear to control genes used in the process.

Finding suggests ways to promote adult heart tissue regeneration
Researchers report that they have been able to remove the 'breaks' that hold back cardiomyocyte proliferation, opening the possibility for treating heart disease by reprogramming adult cardiomyocytes to a more fetal cell state.

Researchers evaluate pMSCs sheets for engineered repair and regeneration of heart tissue
The placenta offers an abundant source of placenta-derived mesenchymal stem cells (pMSCs), which a new study has shown can readily form cell sheets that could be implanted in children with congenital heart defects and offer benefits for heart repair and regeneration compared to commonly used synthetic material-based scaffolds.

Read More: Tissue Regeneration News and Tissue Regeneration Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.